US overdose deaths fell for a third straight year, to 69,973 in 2025

At the peak of the American overdose crisis, in 2022, about 110,000 people died of a drug overdose in a single year. In 2025 it was 69,973. That number is a provisional count, an early estimate the Centers for Disease Control and Prevention will revise as slow-arriving death certificates come in, but it was published on 13 May 2026 and it puts the fall at almost 14 percent in twelve months, the third annual decline in a row. The steepest drop is in the deaths that drove the crisis: those involving opioids, the class of painkilling drugs that includes heroin and fentanyl, fell from 55,296 to 44,564.

How we know

The count comes from the National Center for Health Statistics, the CDC's statistics arm, which publishes provisional counts of overdose deaths every month. Each release covers the twelve months ending in the month named, and each is adjusted for the death certificates that have not yet arrived, so the headline number is a prediction of where the final count will land rather than a tally of records in hand. The May 2026 release covers the year to December 2025. It puts total overdose deaths at 69,973, down from 81,313 for the year to December 2024. Deaths involving synthetic opioids, the laboratory-made kind such as fentanyl rather than those derived from the opium poppy, fell from 48,913 to 38,084. Deaths involving psychostimulants such as methamphetamine fell from 29,852 to 26,181, and those involving cocaine from 22,397 to 19,581. Almost every state fell, and Rhode Island, New York, North Carolina, Alabama and Vermont each fell by 25 percent or more. The pattern is not new. Final data for 2024, published in January 2026, recorded 79,384 overdose deaths among US residents and a 26.2 percent drop in the overdose death rate, the largest single-year fall ever recorded.

Why it matters

Forty thousand fewer deaths a year is a change on the scale of the crisis itself, and it falls mostly on working-age adults. What nobody can yet say with confidence is why. Naloxone, the drug that reverses an opioid overdose within minutes, is carried far more widely than it once was. Test strips that let people check a drug supply for fentanyl have spread. Regulatory changes in China have restricted the chemicals used to manufacture it. Brandon Marshall, a Brown University researcher who studies overdose trends, told the Associated Press he is cautiously optimistic that the arc of the crisis has genuinely changed. Which explanation is right is not an academic question. It decides which of those measures is worth paying for, and the federal government has already stopped paying for the test strips.